159 related articles for article (PubMed ID: 34584583)
21. Utility of faecal calprotectin analysis in adult inflammatory bowel disease.
Smith LA; Gaya DR
World J Gastroenterol; 2012 Dec; 18(46):6782-9. PubMed ID: 23239916
[TBL] [Abstract][Full Text] [Related]
22. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
[TBL] [Abstract][Full Text] [Related]
23. Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.
Hart L; Chavannes M; Kherad O; Maedler C; Mourad N; Marcus V; Afif W; Bitton A; Lakatos PL; Brassard P; Bessissow T
J Crohns Colitis; 2020 Jan; 14(1):46-52. PubMed ID: 31314884
[TBL] [Abstract][Full Text] [Related]
24. The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding.
Vavricka SR; Heinrich H; Buetikofer S; Breitenmoser F; Burri E; Schneider-Yin X; Barman-Aksoezen J; Biedermann L; Scharl M; Zeitz J; Rogler G; Misselwitz B; Sauter M
United European Gastroenterol J; 2018 Aug; 6(7):1007-1014. PubMed ID: 30228888
[TBL] [Abstract][Full Text] [Related]
25. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
Olafsdottir E; Aksnes L; Fluge G; Berstad A
Acta Paediatr; 2002; 91(1):45-50. PubMed ID: 11883817
[TBL] [Abstract][Full Text] [Related]
26. Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis.
Kim S; Park S; Kang Y; Koh H
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):17-21. PubMed ID: 31651657
[TBL] [Abstract][Full Text] [Related]
27. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers in management of inflammatory bowel disease.
Moniuszko A; Wiśniewska A; Rydzewska G
Prz Gastroenterol; 2013; 8(5):275-83. PubMed ID: 24868269
[TBL] [Abstract][Full Text] [Related]
29. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
[TBL] [Abstract][Full Text] [Related]
30. Review article: faecal calprotectin and histologic remission in ulcerative colitis.
D'Amico F; Bonovas S; Danese S; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2020 Apr; 51(7):689-698. PubMed ID: 32048751
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
32. Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.
Labaere D; Smismans A; Van Olmen A; Christiaens P; D'Haens G; Moons V; Cuyle PJ; Frans J; Bossuyt P
United European Gastroenterol J; 2014 Feb; 2(1):30-7. PubMed ID: 24918006
[TBL] [Abstract][Full Text] [Related]
33. Faecal Calprotectin.
Pathirana WGW; Chubb SP; Gillett MJ; Vasikaran SD
Clin Biochem Rev; 2018 Aug; 39(3):77-90. PubMed ID: 30828114
[TBL] [Abstract][Full Text] [Related]
34. Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
Dhaliwal A; Zeino Z; Tomkins C; Cheung M; Nwokolo C; Smith S; Harmston C; Arasaradnam RP
Frontline Gastroenterol; 2015 Jan; 6(1):14-19. PubMed ID: 25580205
[TBL] [Abstract][Full Text] [Related]
35. Faecal calprotectin: Management in inflammatory bowel disease.
Benítez JM; García-Sánchez V
World J Gastrointest Pathophysiol; 2015 Nov; 6(4):203-9. PubMed ID: 26600978
[TBL] [Abstract][Full Text] [Related]
36. Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis.
Bromke MA; Neubauer K; Kempiński R; Krzystek-Korpacka M
J Clin Med; 2021 May; 10(10):. PubMed ID: 34069684
[TBL] [Abstract][Full Text] [Related]
37. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
[TBL] [Abstract][Full Text] [Related]
38. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
Gisbert JP; McNicholl AG
Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
[TBL] [Abstract][Full Text] [Related]
39. Role of faecal calprotectin as non-invasive marker of intestinal inflammation.
Costa F; Mumolo MG; Bellini M; Romano MR; Ceccarelli L; Arpe P; Sterpi C; Marchi S; Maltinti G
Dig Liver Dis; 2003 Sep; 35(9):642-7. PubMed ID: 14563186
[TBL] [Abstract][Full Text] [Related]
40. The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis.
Szymańska E; Meglicka M; Dądalski M; Osiecki M; Kotkowicz-Szczur M; Matuszczyk M; Kierkuś J
Prz Gastroenterol; 2020; 15(4):343-348. PubMed ID: 33777275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
